Say the word immunology, and most biologists will picture the responses enabled by somatic mutation of clonally distributed, highly variable antigen recognition structures. These receptors each interact with one particular species of oligopeptide displayed on one of many major histocompatibility complex molecules to help trigger expansion of the lymphocyte clone bearing them. The resulting elimination of the source of peptide is rewarded by capacity to respond faster to rechallenge with the same antigen.
An immune system so elaborate has a high price. Its steepest cost is that first-response time--about 5-7 days--is orders of magnitude longer than replication time for many microbes. Vertebrates have dealt with this dilemma by engrafting the "adaptive" immune system upon one that Janeway (1989) called "innate," a phylogenetically senior set of devices shared by many metazoans, including insects (Hoffmann et al., 1994) and plants (Ryan and Jagendorf, 1995) . In contrast with adaptive immunity, the innate system detects a much smaller number of much less variable microbial molecular signatures, reading them with genetically stable recognition units predistributed on much larger numbers of cells. Geared for speed and oblivious to evasion of antigen processing, the innate system scans for Gram-negative bacterial lipopolysaccharides, Gram-positive bacterial peptidoglycans and lipoteichoic acid-associated molecules, mycobacterial muramyl dipeptides, mycolic acids and lipoglycans, fungal mannans and glucans, and bacterial CpG-rich nucleotides (Krieg et al., 1995) . Recognition mobilizes an armamentarium of burns, plugs, and poisons, often coupled with liquefaction of infected tissue. Not the least important function of the innate system is to jumpstart its adaptive counterpart (Janeway, 1989) .
A Gene for Innate Immunity
Although nonreliance on somatic mutation is the principle distinguishing feature of the innate immune response, polymorphisms will accumulate in its controlling genes. Some such mutations may confer (or lose) a phenotype, such as increased susceptibility (or decreased resistance) to infection. Such an allele could persist in inbred strains sheltered by unnaturally protective husbandry or could be fixed in the wild by conferral of or linkage with some advantageous, if inapparent, trait. Characterization of such genetic variants could be of enormous value. Their identification could lead to definition of the biochemical basis of an antimicrobial mechanism, as well as identification of patients with special needs for vaccination, other prophylaxis, or intensive treatment.
For these reasons, special notice attend ed the positional cloning of a gene on mouse chromosome 1 termed NRAMP1 (for natural resistance-associated macrophage protein 1) (Vidal et al., 1993) . NRAMP1 was a candidate for the first cloned gene of the mammalian innate immune system whose alleles dictate susceptibility or resistance to infection. One set of microbes to which NRAMP1 was proposed to control innate responses includes Mycobacterium bovis variant bacille Calmette-Gu~rin (BCG), M. intracellulare, and M. lepraemurium. BCG is genetically almost identical to and often serves as a model for M. tuberculosis. The tuberculosis organism probably infects more of the world's human population (one third) and kills more people (nearly 3 million a year) than any other bacterial pathogen and has become the leading cause of death in people infected with human immunodeflciency virus. In human as in mouse, there is evidence for genetic control of susceptibility to tuberculosis as well as to the other major mycobacterial disease, leprosy (see Vidal et al., 1993) . Leishmania species, innate responses to which are controlled by a gene (Lsh) closely linked with or identical to Bcg, are agents of some of the world's most prevalent protozoal diseases. Another closely linked or identical gene, Ity, controls innate resistance to Salmonella typhimurium. Recently, the case for NRAMPI's candidacy as the chromosome 1-situated mediator of resistance to all three organisms in mice--BCG, leishmania, and S. typhimurium--was rendered definitive by the disruption of NRAMP1 in wild-type mice through homologous recombination .
Hence, the following questions are of commanding interest. How does Nrampl work? Does its mechanism have anything to do with enhancing the antimicrobial potential of nitric oxide (NO), as suggested by its cloners (Vidal et al., 1993) ? This minireview summarizes the reasons why NO is a plausible participant in Nrampl's actions, considers cogent counterpoint, and offers speculative resolution to this unfinished story.
NRAMP1 Controls Innate Resistance to Antigenically Dissimilar Pathogens
Nrampl's sequence reveals a highly hydrophobic protein that could thread through a membrane 12 times with its N-terminus in the cytoplasm and N-linked sugars out Gruenheid et al., 1995) . Twenty inbred mouse strains resistant to BCG carried Gly at what was called position 105 within the second putative transmembrane domain (Malo et al., 1994) ; this is now considered position 169 within the fourth transmembrane domain . The change in numerology reflects the recognition of an unspliced intron in the originally reported cDNA (Vidal et al., 1993) , whose absence from subsequently cloned cDNAs restored 64 amino acid residues to the N-terminus Cellier et al., 1994) . In contrast, seven BCG-sensitive strains bore Asp-169, a potentially disruptive mutation (Vidal et al., 1993; Malo et al., 1994) . Nucleotide differences in NRAMP1 coding regions from 27 strains of mice were otherwise silent. Gly-169 was conserved in human, rat, and chicken and is considered wild type (Malo et al., 1994) . Homozygous NRAMPl-deficient mice were precisely as susceptible to pathogens as were homozygous NRAMP1-Asp-169 mice. Thus, G169D is a null allele of NRAMP1 .
At the cDNA level, human NRAMP1, which maps to chromosome 2q35, is 86%-88% identical to that in mouse Blackwell et al., 1995) . Of the 12 predicted transmembrane domains, 10 are totally conserved, despite the expectation that substitution of hydrophobic residues would be tolerated. In particular, the Gly that underwent mutation to Asp in susceptible mice was conserved both in the human cDNA studied by Cellier et al. (1994) and in all 19 individuals studied by Blackwell et al. (1995) . The conservation extends to the atypical intramembranous residues with charged side chains, an evolutionary highlight suggesting that transport of a charged species may be central to the function of Nrampl.
Recent identification of Nramp family members in more distant species revealed zealously conserved features that endorse the notion that these proteins serve to transport ions . Homologs in yeast, rice, and fly are 28%, 40%, and 55% identical to mouse Nrampl . Homology is particularly striking in the first to third and eighth to tenth putative transmembrane regions and in the transport signature between transmembrane domains 8 and 9 . In 6 of the 10 transmembrane segments, a charged residue is invariant. The residue corresponding to Gly-169 of mouse Nrampl is conserved in all other animal species tested (human, rat, chicken, and fly) . The function of these Nrampl homologs is not yet known.
A family of several NRAMPl-related genes is said to be extensively conserved in rodents and humans Vidal et al., 1995) . Mouse NRAMP2 cDNA has been cloned and its mRNA detected in many tissues (Gruenheid et al., 1995) . No evidence implicates the NRAMPl-related mammalian genes in host resistance.
Cytokines and Microbial Products May Regulate NRAMP1
If you were the engineer, in what cells would you express a natural resistance gene and how would you regulate it? The strategy for identification of mouse Nrampl included screening for candidate cDNAs that were restricted to macrophages and constitutively expressed. Ironically, it is not clear that Nrampl does or should meet either criterion. To begin, the cDNA came from a pre-B cell library (Vidal et al., 1993) . Subsequent analysis of NRAMPI's 5'-flanking region (Govoni et al. 1995) revealed no TATA or CAAT sequences typical of inducible genes, but nonetheless divulged multiple y-interferon (IFNy) response elements, IFN-stimulated response elements/IFNy-activating sequences, and NF-IL6-binding sites. The 5'-flanking region of human NRAMP1 likewise contained multiple IFNy response elements as well as NF-KB sites typical of inducible genes . Indeed, IFNy and bacterial lipopolysaccharides markedly augmented the constitutively expressed NRAMP1 mRNA in a macrophage-like cell line (Govoni et al., 1995) . IFNy and granulocyte-macrophage colony-stimulating factor induced apparently de novo expression of NRAMP1 mRNA in primary mouse splenic macrophages (Brown et al., 1995) , even though other investigators found NRAMP1 mRNA constitutively in spleen and presumed that macrophages were the cells expressing it (Vidal et al., 1993 . Such lab-to-lab differences are commonplace in the study of macrophages, perhaps the cells most finely poised to sense environmental signals, even those inapparent to the investigator. Up-regulation of Nrampl in response to infection or inflammation could be rationalized if Nrampl's antimicrobial effectiveness were maximized in concert with other host cell processes subject to similar regulation, such as acidification of phagosomes and generation of reactive oxygen intermediates. Vidal et al. (1993) noted primary sequence homology between a 20 residue region of NRAMP1 separating transmembrane domains 8 and 9 and a motif contributing to the interaction of bacterial periplasmic permeases with ATP-binding proteins. The motif is shared by over 50 proteins, most of them believed to be involved in transmembrane carriage (Gruenheid et al., 1995) , including a nitrate transporter from aspergillus. The latter resemblance spurred Vidal et al. (1993) to hypothesize that Nrampl functions by transporting nitrite from one intracellular compartment, such as cytosol, to a more acidic one, such as phagolysosomes, to be converted therein to NO.
Nrampl and NO
That NO or one of its reaction products has antimicrobial actions is on solid experimental footing. NO synthase type 2 (the inducible isoform, iNOS) is often expressed or suppressed coordinately with antimicrobial activity (e.g., Stenger et al., 1994) . Inhibitors of iNOS often block antimicrobial or antiviral activity in vitro, and in vivo such agents can block the resolution of infections, resulting in lethality (reviewed by . Transfection of cells with iNOS cDNA or organochemical provision of NO can confer resistance to infectious agents (e.g., Karupiah et al., 1993) . Doubts raised by NO's lack of antimicrobial effect against some pathogens when tested alone may be assuaged by recent evidence of synergism with other host molecules. Thus, in the experiments of Pacelli et al. (1995) , neither NO nor H202 was bacteriocidal, but together they killed four logs of Escherichia coli. Similarly, NO alone was nonbacteriostatic, but its adduct with glutathione restricted proliferation of S. typhimurium, and its reaction products with 02-were bacteriocidal . Finally, mice rendered genetically deficient in iNOS through homologous recombination (MacMicking et al., 1995) or unspecified rearrangement (Wei et al., 1995) are less able than wild type to control some infections.
However, matters are complicated by NO's high reactivity and short half-life. In aqueous media, NO combines with oxygen to yield higher oxides whose accumulating endproducts are nitrite and nitrate. Mammalian systems are not known to reduce nitrate. However, at pH -4.5-5.5, lysosomes or phagolysosomes may protonate a significant amount of nitrite to nitrous acid (pKa 3.4). Nitrous acid can dismutate to give rise to NO. This prompted Stuehr and Nathan (1989) to propose that biologically nonreactive nitrite may shuttle NO equivalents through NOscavenging environments into acidic compartments (intracellular or extracellular) to regenerate NO.
An extension of the transport argument envisions Nrampl pumping nitrite from the extracellular fluid into cells, including cells that fail to produce NO biosynthetically. This proposal is inspired by the observation that cells expressing iNOS, constituting a small percentage of a population of transiently transfected cells, suppressed replication of viruses not only in themselves but also in their iNOS-negative neighbors (Karupiah et al., 1993) . The heterogeneity of iNOS expression in the transiently transfected population mirrors that in cell populations in which iNOS is naturally induced by submaximal stimuli. Thus, the transcellular anti-infectious action of NO may be physiologically important, as are the transcellular actions of NO in neurotransmission and regulation of vascular tone. How can cells share cytotoxic amounts of NO? Some NO may survive the diffusional gauntlet of facile reactions with oxygen, superoxide, sulfhydryls, and metals (Lancaster, 1994) . Alternatively, some NO otherwise wasted by reaction with oxygen during its extracellular race could be recouped by importing nitrite and allowing it to equilibrate with acid compartments. The NO arising therein could react with intraphagolysosomal pathogens, either directly or conjointly with superoxide by forming peroxynitrite or its products. Given its lipid solubility, NO could diffuse back from acidic vacuoles into the cytosol to confront other pathogens, such as viruses. In sum, a cell population equipped to expend energy to scavenge nitrite from the medium might achieve more uniformly elevated intracellular NO concentrations than one that cannot. Tests of Nrampl's putative transport functions are awaited. A Wider View of Nrampl's Actions Barton et al, (1994) noted that the proline content of Nrampl's N-terminal region gave it the look of an SH3-binding domain and postulated interactions with tyrosine kinases or cytoskeletal elements. However, such interactions have not been demonstrated, nor would they necessarily narrow the field for possible functions of Nrampl. The prolines are not conserved in Nramp's homologs . Blackwell et al. (1994) recognized that Nrampl exhibits 30% identity over its whole sequence with two similarly sized yeast proteins, SmfF1 and Smf2. The role of the latter in mitochondrial protein import prompted the suggestion that Nrampl in endosomal or phagolysosomal membranes might help load antigenic peptides onto major histocompatibility complex class II molecules . However, the contribution of Smfl and Smf2 to protein import may be indirect , and peptides loaded on class II are believed to be generated intralumenally, not translocated. Blackwell et al. (1994) further proposed that Nrampl may transport L-arginine to enhance the production of NO. However, characterized transporters appear to account for both basal and immunologically stimulated uptake of L-arginine (Cunningham et al., 1995) .
An apparent challenge to the nitrite transport hypothesis for Nrampl's function is the pleiotypy of differences between macrophages from mice bearing resistant and susceptible alleles of NRAMPI. As reviewed by Barton et al. (1995) , wild-type NRAMP1 confers modest increases in microbe-or cytokine-enhanced expression of tumor necrosis factor, iNOS, the KC chemokine, major histocompatiblity complex class II antigens, the respiratory burst, and L-arginine uptake. Thus, Nrampl would appear to affect some early step in macrophage activation. Synergistic interactions have been invoked to explain how small increments in the foregoing phenotypes could lead to multilog differences in microbial burden .
To test the activation hypothesis, Barton et al. (1995) undertook experiments to analyze the mechanism of action of Nrampl. They transfected NRAMP1 cDNA into the RAW 264.7 cell line, whose own NRAMP1 is homozygous susceptible (Asp-169/Asp-169), and assayed stably expressing clones for their respiratory burst, nitrite production, and L-arginine uptake. Small increases in all three assays were seen in some clones. It was not indicated whether the variability correlated with differences in levels of wild-type Nrampl and whether the cells transfected with control vector (NRAMP1-Gly-169) expressed comparable amounts. Unfortunately, enhanced antimicrobial activity--the cardinal feature of Nrampl --went untested, perhaps because transfectable macrophage cell lines replicate too fast to permit meaningful evaluation of antimycobacterial or antileishmanial activity, while fully differentiated macrophages are notoriously difficult to transfect. NO's Unpaired Electron: A Key To Many Locks? NO may be the smallest, least charged, most water-and lipid-soluble carrier available in biological systems for chaperoning a free electron within and between cells. These properties give NO access to the interiors of macromolecules and the ability to alter active sites. For example, NO can regulate ion channels (Dong et al., 1995) , tyrosine kinases and phosphatases (Stamler, 1994) , GTPases (Lander et al., 1995) , and transcription factors (Stamler, 1994) . If Nrampl acts primarily to enhance NO concentrations in a cell population containing point sources of NO, this could regulate multiple facets of cell activation or differentiation, just as NO production in response to nerve growth factor was implicated in the differentiation of neurons (Peunova and Enikolopov, 1995) . The same argument for pleiotropic effects could apply if Nrampl proves to transport ions other than or in addition to nitrite.
Many unanswered questions are raised here. Which cells express Nrampl? Where in the cell does it reside? How is it regulated transcriptionally and posttranscriptionally? What ions does it carry? These should not distract us from other equally important questions. Do NRAMPI's alleles control susceptibility and resistance of human populations to infectious disease? What other allelic systems control innate resistance? How do human macrophages kill pathogens?
